Brief: Galectin Therapeutics Quarterly Loss Per Share $0.16
15/08/2022 13:07
Aug 15 (Reuters) - Galectin Therapeutics Inc GALT.O :
* GALECTIN THERAPEUTICS REPORTS FINANCIAL RESULTS FOR THE
QUARTER
ENDED JUNE 30, 2022 AND PROVIDES BUSINESS UPDATE
* QUARTERLY LOSS PER SHARE $0.16
* GALECTIN THERAPEUTICS - BELIEVES HAS SUFFICIENT CASH TO
FUND
CURRENTLY PLANNED OPERATIONS, RESEARCH AND DEVELOPMENT
ACTIVITIES THROUGH AT LEAST DECEMBER 31, 2024
Source text for Eikon: ID:nGNX6CQkcb
Further company coverage: GALT.O
Recent news on Galectin Therapeutics
See all newsGalectin Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Galectin Therapeutics Reports June 30, 2026 Financial Results
Galectin Therapeutics Q2 loss widens
Galectin Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview
Galectin Therapeutics rises as FDA clears path for late-stage liver drug study